AT-Patch (ATP-C130/ATP-C70) vs Analytic for Hemodynamic Instability (AHI)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AT-Patch (ATP-C130/ATP-C70)

by ATsens Co.

Analytic for Hemodynamic Instability (AHI)

by Fifth Eye Inc.

AI Verdict

Tool A, AT-Patch, is an ambulatory ECG monitor focused on long-term arrhythmia detection for out-of-hospital patients, providing detailed ECG analysis. In contrast, Tool B, Analytic for Hemodynamic Instability (AHI), is an in-hospital clinical decision support system that uses continuous ECG data to predict hemodynamic instability in real-time. While both utilize AI and ECG in cardiology, their distinct deployment environments and primary clinical objectives make them adjacent rather than direct competitors.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if your primary need is long-term, continuous ambulatory ECG monitoring for patients outside of a hospital setting. This wearable device is ideal for diagnosing intermittent arrhythmias or assessing cardiac activity over an extended period (up to 14 days) while allowing patients to maintain normal daily activities, including showering. Its compact design and integrated AI analysis software are well-suited for comprehensive outpatient cardiac diagnostics and remote patient monitoring.

View AT-Patch (ATP-C130/ATP-C70) →

Choose Analytic for Hemodynamic Instability (AHI) if…

Choose Analytic for Hemodynamic Instability (AHI) if you require real-time, AI-driven clinical decision support for continuously monitoring adult in-hospital patients at risk of hemodynamic deterioration. This software is best suited for critical care, emergency departments, or general hospital wards where early prediction of instability, hours before traditional vital signs indicate a problem, can enable proactive interventions and potentially improve patient outcomes by reducing nurse surveillance burden.

View Analytic for Hemodynamic Instability (AHI) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AT-Patch (ATP-C130/ATP-C70)	Analytic for Hemodynamic Instability (AHI)
Deployment	Wearable device for patients; analysis software deployed on-premise at medical institutions.	Integrates with existing hospital ECGs and can be deployed through platforms like Medical Informatics Corp.'s Sickbay™ and VitalConnect's remote patient monitoring solution.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AT-Patch (ATP-C130/ATP-C70)

AT-Patch offers superior patient usability with its compact, lightweight, shower-proof wearable design that requires no charging or electrode replacement during monitoring. The accompanying AT-Note smartphone app provides live ECG viewing and symptom recording, enhancing patient engagement and ease of use for continuous monitoring.

Clinical Value

Analytic for Hemodynamic Instability (AHI)

While both tools are FDA-cleared and offer significant clinical benefits, Fifth Eye's AHI provides a unique predictive capability for hemodynamic instability, offering early warnings up to 26 hours ahead of traditional vital signs. This proactive identification of critical patient deterioration can enable earlier interventions and potentially prevent adverse events in acute care settings.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, making a direct comparison of their pricing and overall value proposition impossible. Both require direct contact with the vendor for details, indicating a lack of transparency in this dimension.

Enterprise Readiness

Analytic for Hemodynamic Instability (AHI)

Fifth Eye's AHI is deployed as Software as a Medical Device (SaMD) that integrates with existing in-hospital monitoring platforms and is accessible via any browser-enabled device. This approach suggests easier and more scalable enterprise integration compared to AT-Patch's on-premise analysis software deployment, which may require more specific IT infrastructure.

Innovation

Analytic for Hemodynamic Instability (AHI)

Both tools leverage AI, but AHI's core innovation lies in its predictive analytics for hemodynamic instability, providing early warnings significantly ahead of traditional vital signs. This capability to anticipate acute, life-threatening events represents a higher degree of innovation in clinical decision support compared to AT-Patch's advanced diagnostic monitoring.

Support & Docs

AT-Patch (ATP-C130/ATP-C70)

ATsens' AT-Patch website explicitly features a 'Support' section with FAQs, manuals, software downloads, and videos, indicating readily accessible resources for users. In contrast, Fifth Eye's website primarily offers a 'Contact Us' option without a clearly visible dedicated support or documentation portal.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AT-Patch (ATP-C130/ATP-C70)	Analytic for Hemodynamic Instability (AHI)
Product Name	AT-Patch (ATP-C130/ATP-C70)	Analytic for Hemodynamic Instability (AHI)
Company	ATsens Co.	Fifth Eye
Tagline	Ambulatory ECG Monitor for Continuous Cardiac Monitoring	Predicting hemodynamic instability earlier than vital signs for proactive patient care.
Key Functionality	Up to 14 days of continuous ECG monitoring with AI/machine learning algorithms for ECG analysis.	Predicts hemodynamic instability earlier than vital signs using continuous ECG lead II data and AI-driven technology.
Target User/Setting	Patients (wearable device) and medical institutions (analysis software)	Healthcare professionals in in-hospital settings (e.g., Critical Care, Emergency Medicine)

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and Analytic for Hemodynamic Instability (AHI).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of each tool?

AT-Patch is an FDA-cleared wearable ECG monitor designed for up to 14 days of continuous cardiac monitoring, primarily for enhanced arrhythmia detection. AHI System is an FDA-cleared, AI-driven clinical decision support software that continuously monitors adult in-hospital patients for early signs of hemodynamic instability.

How do these tools differ in their patient monitoring approach and setting?

AT-Patch uses a compact, lightweight wearable device for ambulatory patients, offering continuous ECG monitoring for up to 14 days without charging or electrode replacement. AHI System is a Software as a Medical Device (SaMD) integrated into existing in-hospital monitoring platforms, utilizing continuous ECG lead II data to provide real-time clinical analytics for in-hospital patients.

What type of data do these tools utilize for their analysis?

AT-Patch acquires accurate ECG signals through its high-performance sensor chip and short-length electrode from the wearable device. AHI System analyzes continuous ECG lead II data obtained from existing in-hospital monitoring platforms.

What are the key benefits each tool offers to healthcare professionals?

AT-Patch provides AI/machine learning algorithms for ECG analysis, offering rapid and elaborate analysis of ECG data to assist in accurate diagnosis and improved work efficiency. AHI System offers early warnings of hemodynamic instability hours ahead of traditional vital signs, reducing nurse surveillance burden and streamlining workflow with easy-to-interpret visual indicators.

Which medical specialties are these tools primarily intended for?

AT-Patch is intended for Cardiology, Family Medicine, and Internal Medicine. AHI System is primarily for Cardiology, Critical Care, and Emergency Medicine.